A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation studyJesse J. Swen, Roelof Bosch, Cathelijne H. van der Wouden et al.|The Lancet|2023Cited by 508
Perfusion abnormalities in mild cognitive impairment and mild dementia in Alzheimer’s disease measured by pulsed arterial spin labeling MRIPanagiotis Alexopoulos, Christine Preibisch, Annette Förschler et al.|European Archives of Psychiatry and Clinical Neuroscience|2011Cited by 124
Complex posttraumatic stress disorder: The need to consolidate a distinct clinical syndrome or to reevaluate features of psychiatric disorders following interpersonal trauma?Evangelia Giourou, Eleni Jelastopulu, Μαρία Σκώκου et al.|World Journal of Psychiatry|2018Cited by 91
Depression in Multiple Sclerosis: A Review of Assessment and Treatment Approaches in Adult and Pediatric PopulationsΜαρία Σκώκου, Philippos Gourzis, Evanthia Soubasi|ISRN Neurology|2012Cited by 84
Suicidality in the “prodromal” phase of schizophreniaIoannis Andriopoulos, Stavroula Beratis, John Ellul et al.|Comprehensive Psychiatry|2010Cited by 67